ID: 26524 | large tumor suppressor kinase 2 [Homo sapiens (human)] | Chromosome 13, NC_000013.11 (20973036..21061586, complement) | KPM | 604861 |
ID: 7157 | tumor protein p53 [Homo sapiens (human)] | Chromosome 17, NC_000017.11 (7668421..7687490, complement) | BCC7, BMFS5, LFS1, P53, TRP53 | 191170 |
ID: 10413 | Yes1 associated transcriptional regulator [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (102110447..102233424) | COB1, YAP, YAP-1, YAP2, YAP65, YKI | 606608 |
ID: 2146 | enhancer of zeste 2 polycomb repressive complex 2 subunit [Homo sapiens (human)] | Chromosome 7, NC_000007.14 (148807383..148884291, complement) | ENX-1, ENX1b, KMT6, KMT6A, WVS, WVS2, EZH2 | 601573 |
ID: 3091 | hypoxia inducible factor 1 subunit alpha [Homo sapiens (human)] | Chromosome 14, NC_000014.9 (61695513..61748258) | HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | 603348 |
ID: 2064 | erb-b2 receptor tyrosine kinase 2 [Homo sapiens (human)] | Chromosome 17, NC_000017.11 (39688094..39728658) | CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2) | 164870 |
ID: 2099 | estrogen receptor 1 [Homo sapiens (human)] | Chromosome 6, NC_000006.12 (151656672..152129619) | ER, ESR, ESRA, ESTRR, Era, NR3A1 | 133430 |
ID: 367 | androgen receptor [Homo sapiens (human)] | Chromosome X, NC_000023.11 (67544021..67730619) | AIS8, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM, AR | 313700 |
ID: 673 | B-Raf proto-oncogene, serine/threonine kinase [Homo sapiens (human)] | Chromosome 7, NC_000007.14 (140713328..140924929, complement) | B-RAF1, B-raf-1, BRAF1, NS7, RAFB1, BRAF | 164757 |
ID: 4318 | matrix metallopeptidase 9 [Homo sapiens (human)] | Chromosome 20, NC_000020.11 (46008908..46016561) | CLG4B, GELB, MANDP2, MMP-9 | 120361 |
ID: 207 | AKT serine/threonine kinase 1 [Homo sapiens (human)] | Chromosome 14, NC_000014.9 (104769349..104795748, complement) | AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | 164730 |
ID: 1499 | catenin beta 1 [Homo sapiens (human)] | Chromosome 3, NC_000003.12 (41199505..41240443) | CTNNB, EVR7, MRD19, NEDSDV, armadillo | 116806 |
ID: 1029 | cyclin dependent kinase inhibitor 2A [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (21967752..21995324, complement) | ARF, CAI2, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | 600160 |
ID: 4609 | MYC proto-oncogene, bHLH transcription factor [Homo sapiens (human)] | Chromosome 8, NC_000008.11 (127735434..127742951) | MRTLC, bHLHe39, c-Myc, MYC | 190080 |
ID: 1026 | cyclin dependent kinase inhibitor 1A [Homo sapiens (human)] | Chromosome 6, NC_000006.12 (36676463..36687332) | CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | 116899 |
ID: 4193 | MDM2 proto-oncogene [Homo sapiens (human)] | Chromosome 12, NC_000012.12 (68808172..68850686) | ACTFS, HDMX, LSKB, hdm2 | 164785 |
ID: 4313 | matrix metallopeptidase 2 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (55478830..55506691) | CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1 | 120360 |
ID: 960 | CD44 molecule (IN blood group) [Homo sapiens (human)] | Chromosome 11, NC_000011.10 (35139171..35232402) | CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL, HUTCH-1, HUTCH-I, Hermes-1, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | 107269 |
ID: 4851 | notch receptor 1 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (136494433..136546048, complement) | AOS5, AOVD1, TAN1, hN1 | 190198 |
ID: 4233 | MET proto-oncogene, receptor tyrosine kinase [Homo sapiens (human)] | Chromosome 7, NC_000007.14 (116672196..116798377) | AUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met | 164860 |